The postoperative outcomes, determined at least 1 year after surgery, were CDVA; UDVA; contrast sensitivity function under photopic, mesopic, and mesopic with glare conditions; ECC; IOP; keratometry (Scheimpflug photography); and total ocular aberration (Hartmann-Shack aberrometry).
Twelve eyes had implantation of an Artisan pIOL (rigid pIOL group) and 18 eyes, of an Artiflex pIOL (flexible pIOL group). The mean preoperative CDVA was 0.04 logMAR selleck inhibitor +/- 0.01 (SD) in both groups (P>.5). The mean postoperative CDVA was 0.01 +/- 0.02 logMAR in the rigid IOL group and 0.01 +/- 0.06 logMAR in the flexible IOL group (P>.9). The photopic contrast sensitivity function was better with the rigid pIOL, and the mesopic contrast sensitivity function was slightly better
with the flexible pIOL; however, neither difference was statistically learn more significant.
CONCLUSIONS: Optic quality, measured by modulation transfer function and evaluated by average modulation, was approximately 13% better with the rigid pIOL than with the flexible pIOL. However, the difference was not enough to affect visual quality. At 1 year, the 2 groups had similar CDVA and contrast sensitivity function values, indicating that other optical or neural factors compensate for differences in optic quality. J Cataract Refract Surg 2009, 35:1911-1917 (C) 2009 ASCRS and ESCRS”
“Primary DMXAA solubility dmso musculoskeletal hydatidosis is less frequent than
hydatidosis of the parenchymal organs. This localization has been little studied and so there is little information in the literature on the subsequent disease evolution. We present a case of primary hydatidosis of the abductor muscle that came to medical attention very late. After complete surgical removal of the huge mass, a secondary bone localization developed, causing a femoral pertrochanteric pathological fracture. The case described is exceptional in view of both the localization and the great size of the primary multi-lobed muscle hydatid cyst. We underline the difficulties of diagnosis and treatment of both the primary muscle localization and the secondary bone recurrence. (C) 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.